This study investigates if an experimental blood test can help predict how well cancer will remain under control with treatment. Ther experimental blood test involves measuring mircoRNAs. MicroRNAs are small molecules which help regulate how genes are expressed. This information may help researchers guide treatment for other patients in the future.
Study Type
OBSERVATIONAL
Enrollment
7
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States
Patient Clinical Status - Liver Transplant
Undergoing liver transplant
Time frame: At study completion, up to 12 months
Patient Clinical Status - Death
Will assess the following: death
Time frame: At study completion, up to 12 months
Patient Clinical Status - Candidacy
No longer candidate for transplantation for reasons other than tumor progression
Time frame: At study completion, up to 12 months
Patient Clinical Status
No longer candidate for transplantation due to tumor progression despite loco-regional therapy efforts
Time frame: At study completion, up to 12 months
Incidence of "Wait List Drop Off"
Will be estimated and presented with a Clopper-Pearson exact binomial confidence interval
Time frame: At study completion, up to 12 months
Time to "Wait List Drop Off"
Cox proportinal hazards modeling will be used to investigate the associations of each micro ribonucleic acid (miRNO) with time to "wait list drop off"
Time frame: Up to 12 months
Clinical Status of the subset of patients successfully reaching liver transplant
Logistic regression modeling will be used to investigate the correlation of each miRNA with clincial status (alive without recurrence vs. recurrence or death) within one year of transplant will be cinducted in the subset of those undergoing transplant. The p-values will be adjusted for false discovery rate inflation by the methods of Benjamni \& Hochberg (1995) for both secondary analyses, respectively
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: At 1 year after transplantation